30 results
idsa infections opportunistic prevention hematology ibd syndrome tb tuberculosis differential hemeonc hemophagocytic hlh latenttb leukemia lymphohistiocytosis mycobacterium neurology rheumatology ulcerative
Relapsing Acute Severe Ulcerative Colitis - Management Algorithm Loss of Response: • (Re)consult Colorectal Surgery • Assess
Ulcerative Colitis - Management ... Adherence • Assess Disease ... Activity: Flex ... Diff. & CMV COVID ... #Treatment
Multiple Myeloma Diagnosis and Management Summary Clinical Signs: • hyperCalcemia 28% (bone demineralization) • Renal disease 48%
and Management ... demineralization) • Renal disease ... marrow plasma cells ... is also >100 CMC ... #Management #oncology
Hemophagocytic Lymphohistiocytosis (HLH) Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
+: Virus (EBV, CMV ... • Autoimmune diseases ... or biologics (CMV ... Unknown cause Treatment ... #management #treatment
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS Recommendations
, and sexually active ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Diagnosis ... Tuberculosis Treatment ... Initiating Treatment ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS Preventing CMV Disease: • CMV end-organ disease is best
Disease: • CMV ... CD4 count >100 cells ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Aplastic Anemia - Overview Who? • M = F • 3 peaks: 1) Childhood 2) 15-25 years 3) >60 years What? • Aplastic anemia
- EBV - CMV ... aplastic anemia Treatment ... Aplastic #Anemia #oncology ... #hematology #diagnosis ... #management
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Diagnosis ... Tuberculosis Treatment ... Initiating Treatment ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS Treating Isospora belli Infection General Management Considerations: • Fluid
Infection General Management ... without evidence of active ... IDSA #Prevention #Treatment ... #infections #HIVAIDS ... #pharmacology
Differentiation Syndrome in APML Epidemiology: • Incidence: common in APL (2-48% depending on the study) • Triggers:
Triggers: ATRA treatment ... Release from blast cells ... coagulopathy, RRT/IMV ... #management #hematology ... #oncology
No results found for "Lellis pharmacology algorithm treatment hivaids disease management oncology diagnosis activetb cmv"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Lellis #pharmacology #algorithm #treatment #hivaids #disease #management #oncology #diagnosis #activetb #cmv